Christchurch, New Zealand Clinical Trials

Adenocarcinoma

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Angina

Research Site

Patients are needed to participate in a clinical research study evaluating AMG 334 and Placebo for the treatment of Stable Angina

Arthritis and Arthritic Pain

Site Reference ID/Investigator# 146019

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Atherosclerosis

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Breast Cancer

Christchurch Hospital

A Phase 1 clinical study for patients with Breast Neoplasms or Stomach Neoplasms

Chronic Lymphocytic Leukemia

Canterbury Health Laboratories

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Chronic Pain

After Hours Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Cashmere Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Pacific Radiology Wigram Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Southern Clinical Trials Ltd Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Southern Cross Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

View More »

St George Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

COPD (Chronic Obstructive Pulmonary Disease)

Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Crohn's Disease

Christchurch Hospital

A clinical trial to evaluate treatments using GS-5745 and Placebo for patients with Crohn's Disease

Christchurch Hospital

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

Site Reference ID/Investigator# 146019

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Diabetes Mellitus, Type 1

1245.72.64001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 1

Lexicon Investigational Site

Patients are needed to participate in a clinical research study of Sotagliflozin and Placebo to evaluate Type 1 Diabetes Mellitus (T1DM) or High Level of Sugar (Glucose) in the Blood

Lexicon Investigational Site

Patients are needed to participate in a clinical research study of Sotagliflozin and Placebo to evaluate Type 1 Diabetes Mellitus (T1DM) or High Level of Sugar (Glucose) in the Blood

Diabetes Mellitus, Type 2

Research Site

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Research Site Updated

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Diabetic Kidney Disease

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Research Site Updated

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Emphysema

Christchurch Hospital NZ

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

Heart Attack (Myocardial Infarction)

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Shirley Ltd

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hemophilia

Research Site

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Hepatitis

Christchurch Clinical Studies

A Phase 2 clinical study for patients with Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV) or Hepatitis C Genotype 1

High Cholesterol (Hyperlipidemia)

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Shirley Ltd

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hypertriglyceridemia

Research Site

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Inflammatory Bowel Disease

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Influenza

Research Site

A Phase 2 clinical study for patients with Influenza

Kidney Disease

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Research Site

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Research Site Updated

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Site Reference ID/Investigator# 134228

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Leukemia

Canterbury Health Laboratories

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

View More »

Research Site

A clinical trial seeking patients for a research study for the treatment of Neoplasms, Leukemia, Acute Myeloid Leukemia (AML)

Research Site

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

Lung Cancer

Christchurch Hospital

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Lung Disease

Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Lymphocytic Leukemia, Chronic

Canterbury Health Laboratories

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

View More »

Research Site

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

Lymphoma

Research Site

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Canterbury Health Laboratories

Patients are needed to participate in a clinical research study for the treatment of Diffuse Large B-cell Lymphoma

Lymphoma, B-Cell

Research Site

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Canterbury Health Laboratories

Patients are needed to participate in a clinical research study for the treatment of Diffuse Large B-cell Lymphoma

Neoplasms

Research Site

A clinical research study of vemurafenib for the treatment of Neoplasms

Christchurch Hospital

A Phase 1 clinical study for patients with Breast Neoplasms or Stomach Neoplasms

Nephropathy

Site Reference ID/Investigator# 134228

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Non-Hodgkin's Lymphoma

Research Site

A clinical trial seeking patients for a research study for the treatment of Non-Hodgkin's Lymphoma, Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)

Non-Small Cell Lung Cancer

Christchurch Hospital

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Christchurch Hospital NZ

A clinical trial seeking patients for a research study for the treatment of First Line Non-Small Cell Lung Cancer (NSCLC) (JAVELIN Lung 100)

Obesity

Research Site

A clinical research study of APD356-Lorcaserin hydrochloride and Placebo

Osteoarthritis

After Hours Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Cashmere Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Pacific Radiology Wigram Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Southern Clinical Trials Ltd Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Southern Cross Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

View More »

St George Radiology Updated

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Ovarian Cancer

Site Reference ID/Investigator# 145124

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Canterbury Urology Research Trust

A clinical trial to evaluate treatments for patients with Prostate Cancer, Metastatic Prostate Cancer or Castration-resistant Prostate Cancer

Rheumatoid Arthritis

Site Reference ID/Investigator# 146019

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Spinal Cord Injuries

Canterbury District Health Board, Burwood Hospital

A clinical trial to evaluate treatments using Rehabilitation using REX for patients with Spinal Cord Injury

Stomach Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Stroke

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Shirley Ltd

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Ulcerative Colitis

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Receptos Study Site 876

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe

Ulcers

Research Site

A Phase 2/Phase 3 clinical study for patients with Ulcerative Colitis, Moderate to Severe Active Ulcerative Colitis

Research Site

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

Christchurch Hospital

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Receptos Study Site 876

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe